{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:14:15Z","timestamp":1793794455559,"version":"4.6.1"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T00:00:00Z","timestamp":1571011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Fonds de la Recherche Qu\u00e9bec-Sant\u00e9"},{"name":"R\u00e9seau de bioimagerie du Qu\u00e9bec"},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP 103230"],"award-info":[{"award-number":["MOP 103230"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PTJ 166049"],"award-info":[{"award-number":["PTJ 166049"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002879","name":"Canadian HIV Trials Network, Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CTN 257"],"award-info":[{"award-number":["CTN 257"]}],"id":[{"id":"10.13039\/501100002879","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008220","name":"Canadian Foundation for AIDS Research","doi-asserted-by":"publisher","award":["02-512"],"award-info":[{"award-number":["02-512"]}],"id":[{"id":"10.13039\/100008220","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Cytomegalovirus (CMV) seropositivity and anti-CMV immunoglobulin G (IgG) levels are associated with adverse health outcomes in elderly populations. Among people living with human immunodeficiency virus (PLWH), CMV seropositivity has been associated with persistent CD8 T-cell elevation and increased risk of developing non-AIDS comorbidities despite long-term antiretroviral therapy (ART). Herein, we investigated whether CMV seropositivity and elevation of anti-CMV IgG levels were associated with increased epithelial gut damage, microbial translocation, and systemic inflammation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 150 PLWH (79 ART-naive and 71 ART-treated) were compared to 26 without human immunodeficiency virus (HIV) infection (uninfected controls). Plasma markers of HIV disease progression, epithelial gut damage, microbial translocation, nonspecific B-cell activation, anti-CMV and anti\u2013Epstein-Barr virus (EBV) IgG levels, and proinflammatory cytokines were measured.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>CMV seropositivity and elevated anti-CMV IgG levels were associated with markers of epithelial gut damage, microbial translocation, and inflammation in PLWH and participants without HIV infection. In contrast, total nonspecific IgG, immunoglobulin M, immunoglobulin A, and anti-EBV IgG levels were not associated with these markers. CMV seropositivity was associated with markers of epithelial gut damage, microbial translocation, and inflammation independent of sociodemographic and behavioral characteristics of the study population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>CMV-seropositive people with and without HIV had increased epithelial gut damage, microbial translocation, and inflammation. Furthermore, anti-CMV IgG levels were independently associated with increased epithelial gut damage and microbial translocation. CMV coinfection may partially explain persistent gut damage, microbial translocation, and inflammation in ART-treated PLWH.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciz1001","type":"journal-article","created":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T08:17:09Z","timestamp":1570522629000},"page":"1438-1446","source":"Crossref","is-referenced-by-count":46,"title":["Cytomegalovirus Seropositivity Is Associated With Increased Microbial Translocation in People Living With Human Immunodeficiency Virus and Uninfected Controls"],"prefix":"10.1093","volume":"71","author":[{"given":"Rayoun","family":"Ramendra","sequence":"first","affiliation":[{"name":"Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada"},{"name":"Infectious Diseases and Immunity in Global Health Program, Research Institute, McGill University Health Centre, Montreal, Quebec, Canada"},{"name":"Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Isnard","sequence":"additional","affiliation":[{"name":"Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada"},{"name":"Infectious Diseases and Immunity in Global Health Program, Research Institute, McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lin","sequence":"additional","affiliation":[{"name":"Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada"},{"name":"Infectious Diseases and Immunity in Global Health Program, Research Institute, McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Fombuena","sequence":"additional","affiliation":[{"name":"Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada"},{"name":"Infectious Diseases and Immunity in Global Health Program, Research Institute, McGill University Health Centre, Montreal, Quebec, Canada"},{"name":"Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada"},{"name":"Infectious Diseases and Immunity in Global Health Program, Research Institute, McGill University Health Centre, Montreal, Quebec, Canada"},{"name":"Chongqing Public Health Medical Center, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Mehraj","sequence":"additional","affiliation":[{"name":"Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada"},{"name":"Infectious Diseases and Immunity in Global Health Program, Research Institute, McGill University Health Centre, Montreal, Quebec, Canada"},{"name":"Centre de Recherche du Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Associates of Cape Cod Inc, Falmouth, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Finkelman","sequence":"additional","affiliation":[{"name":"Associates of Cape Cod Inc, Falmouth, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Costiniuk","sequence":"additional","affiliation":[{"name":"Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada"},{"name":"Infectious Diseases and Immunity in Global Health Program, Research Institute, McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Lebouch\u00e9","sequence":"additional","affiliation":[{"name":"Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada"},{"name":"Infectious Diseases and Immunity in Global Health Program, Research Institute, McGill University Health Centre, Montreal, Quebec, Canada"},{"name":"Department of Family Medicine, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Chartrand-Lefebvre","sequence":"additional","affiliation":[{"name":"Centre de Recherche du Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Durand","sequence":"additional","affiliation":[{"name":"Centre de Recherche du Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Tremblay","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada"},{"name":"Centre de Recherche du Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petronela","family":"Ancuta","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada"},{"name":"Centre de Recherche du Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Boivin","sequence":"additional","affiliation":[{"name":"Department of Microbiology-Immunology and Infectious Diseases, Laval University, Quebec City, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Routy","sequence":"additional","affiliation":[{"name":"Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada"},{"name":"Infectious Diseases and Immunity in Global Health Program, Research Institute, McGill University Health Centre, Montreal, Quebec, Canada"},{"name":"Division of Hematology, McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,14]]},"reference":[{"key":"2020091210441376900_CIT0001","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nri.2016.38","article-title":"T cell responses to cytomegalovirus","volume":"16","author":"Klenerman","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"2020091210441376900_CIT0002","doi-asserted-by":"crossref","first-page":"6156581","DOI":"10.1155\/2019\/6156581","article-title":"A practical review of cytomegalovirus in gastroenterology and hepatology","volume":"2019","author":"Fakhreddine","year":"2019","journal-title":"Gastroenterol Res Pract"},{"key":"2020091210441376900_CIT0003","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/infdis\/jix080","article-title":"CMV-specific T-cell responses at older ages: broad responses with a large central memory component may be key to long-term survival","volume":"215","author":"Bajwa","year":"2017","journal-title":"J Infect Dis"},{"key":"2020091210441376900_CIT0004","doi-asserted-by":"crossref","DOI":"10.3390\/v10080444","article-title":"Molecular determinants and the regulation of human cytomegalovirus latency and reactivation","volume":"10","author":"Collins-McMillen","year":"2018","journal-title":"Viruses"},{"key":"2020091210441376900_CIT0005","doi-asserted-by":"crossref","first-page":"e1006202","DOI":"10.1371\/journal.ppat.1006202","article-title":"Replication of CMV in the gut of HIV-infected individuals and epithelial barrier dysfunction","volume":"13","author":"Maidji","year":"2017","journal-title":"PLoS Pathog"},{"key":"2020091210441376900_CIT0006","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/imr.12079","article-title":"HIV-associated chronic immune activation","volume":"254","author":"Paiardini","year":"2013","journal-title":"Immunol Rev"},{"key":"2020091210441376900_CIT0007","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/s41385-018-0032-5","article-title":"Intestinal damage precedes mucosal immune dysfunction in SIV infection","volume":"11","author":"Hensley-McBain","year":"2018","journal-title":"Mucosal Immunol"},{"key":"2020091210441376900_CIT0008","doi-asserted-by":"crossref","first-page":"e3162","DOI":"10.1097\/MD.0000000000003162","article-title":"(1\u21923)-\u03b2-D-glucan levels correlate with neurocognitive functioning in HIV-infected persons on suppressive antiretroviral therapy: a cohort study","volume":"95","author":"Hoenigl","year":"2016","journal-title":"Medicine"},{"key":"2020091210441376900_CIT0009","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat Med"},{"key":"2020091210441376900_CIT0010","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) is predictive of non-AIDS events during antiretroviral therapy-mediated viral suppression [manuscript published online ahead of print 12 November 2018]","author":"Hoenigl","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2020091210441376900_CIT0011","article-title":"Circulating (1--&gt;3)-beta-D-glucan is associated with immune activation during HIV infection [manuscript published online ahead of print 16 March 2019]","author":"Mehraj","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020091210441376900_CIT0012","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/infdis\/jiu238","article-title":"Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection","volume":"210","author":"Hunt","year":"2014","journal-title":"J Infect Dis"},{"key":"2020091210441376900_CIT0013","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1093\/infdis\/jiw217","article-title":"Cytomegalovirus and HIV: a dangerous pas de deux","volume":"214","author":"Gianella","year":"2016","journal-title":"J Infect Dis"},{"key":"2020091210441376900_CIT0014","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/cid\/civ840","article-title":"CD8 T-cell expansion and Inflammation linked to CMV coinfection in ART-treated HIV infection","volume":"62","author":"Freeman","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2020091210441376900_CIT0015","doi-asserted-by":"crossref","first-page":"20052","DOI":"10.7448\/IAS.18.1.20052","article-title":"CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients","volume":"18","author":"Lu","year":"2015","journal-title":"J Int AIDS Soc"},{"key":"2020091210441376900_CIT0016","doi-asserted-by":"crossref","first-page":"e0165774","DOI":"10.1371\/journal.pone.0165774","article-title":"CMV+ serostatus associates negatively with CD4:CD8 ratio normalization in controlled HIV-infected patients on cART","volume":"11","author":"Poizot-Martin","year":"2016","journal-title":"PLoS One"},{"key":"2020091210441376900_CIT0017","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1093\/infdis\/jis276","article-title":"Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women","volume":"205","author":"Parrinello","year":"2012","journal-title":"J Infect Dis"},{"key":"2020091210441376900_CIT0018","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/infdis\/jiu417","article-title":"Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients","volume":"211","author":"Lichtner","year":"2015","journal-title":"J Infect Dis"},{"key":"2020091210441376900_CIT0019","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/cid\/ciy170","article-title":"Higher anti-cytomegalovirus immunoglobulin G concentrations are associated with worse neurocognitive performance during suppressive antiretroviral therapy","volume":"67","author":"Letendre","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2020091210441376900_CIT0020","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/infdis\/jir060","article-title":"Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy","volume":"203","author":"Hunt","year":"2011","journal-title":"J Infect Dis"},{"key":"2020091210441376900_CIT0021","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1097\/QAD.0000000000000405","article-title":"Immune resilience in HIV-infected individuals seronegative for cytomegalovirus","volume":"28","author":"Barrett","year":"2014","journal-title":"AIDS"},{"key":"2020091210441376900_CIT0022","doi-asserted-by":"crossref","first-page":"e2034","DOI":"10.1002\/rmv.2034","article-title":"Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis","volume":"29","author":"Zuhair","year":"2019","journal-title":"Rev Med Virol"},{"key":"2020091210441376900_CIT0023","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1186\/s12879-017-2692-2","article-title":"The Canadian HIV and aging cohort study\u2014determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol","volume":"17","author":"Durand","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2020091210441376900_CIT0024","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25034","article-title":"Socio-economic status and time trends associated with early ART initiation following primary HIV infection in Montreal, Canada: 1996 to 2015","volume":"21","author":"Mehraj","year":"2018","journal-title":"J Int AIDS Soc"},{"key":"2020091210441376900_CIT0025","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/infdis\/jix367","article-title":"Intestinal damage and inflammatory biomarkers in human immunodeficiency virus (HIV)-exposed and HIV-infected Zimbabwean infants","volume":"216","author":"Prendergast","year":"2017","journal-title":"J Infect Dis"},{"key":"2020091210441376900_CIT0026","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fimmu.2019.00289","article-title":"CXCL13 as a biomarker of immune activation during early and chronic HIV infection","volume":"10","author":"Mehraj","year":"2019","journal-title":"Front Immunol"},{"key":"2020091210441376900_CIT0027","doi-asserted-by":"crossref","first-page":"ofy288","DOI":"10.1093\/ofid\/ofy288","article-title":"I-FABP is higher in people with chronic HIV than elite controllers, related to sugar and fatty acid intake and inversely related to body fat in people with HIV","volume":"5","author":"Cheru","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2020091210441376900_CIT0028","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3389\/fendo.2019.00471","article-title":"CXCL13 and its receptor CXCR5 in cancer: inflammation, immune response, and beyond","volume":"10","author":"Kazanietz","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2020091210441376900_CIT0029","doi-asserted-by":"crossref","first-page":"20697","DOI":"10.7448\/IAS.19.1.20697","article-title":"Elevation and persistence of CD8 T-cells in HIV infection: the Achilles heel in the ART era","volume":"19","author":"Cao","year":"2016","journal-title":"J Int AIDS Soc"},{"key":"2020091210441376900_CIT0030","doi-asserted-by":"crossref","first-page":"434","DOI":"10.21037\/atm.2017.08.38","article-title":"Very early antiretroviral therapy permits CD8 T cells to keep HIV reservoirs at bay","volume":"5","author":"Routy","year":"2017","journal-title":"Ann Transl Med"},{"key":"2020091210441376900_CIT0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12979-015-0056-6","article-title":"Cytomegalovirus viral load within blood increases markedly in healthy people over the age of 70 years","volume":"13","author":"Parry","year":"2016","journal-title":"Immun Ageing"},{"key":"2020091210441376900_CIT0032","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1182\/blood-2015-03-636548","article-title":"Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia","volume":"126","author":"Kim","year":"2015","journal-title":"Blood"},{"key":"2020091210441376900_CIT0033","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1097\/QAD.0000000000001579","article-title":"Effect of cytomegalovirus and Epstein-Barr virus replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals","volume":"31","author":"Gianella","year":"2017","journal-title":"AIDS"},{"key":"2020091210441376900_CIT0034","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s40265-016-0546-7","article-title":"Serious non-AIDS events: therapeutic targets of immune activation and chronic inflammation in HIV infection","volume":"76","author":"Hsu","year":"2016","journal-title":"Drugs"},{"key":"2020091210441376900_CIT0035","doi-asserted-by":"crossref","first-page":"e0117039","DOI":"10.1371\/journal.pone.0117039","article-title":"Comprehensive evaluation of the immune risk phenotype in successfully treated HIV-infected individuals","volume":"10","author":"Ndumbi","year":"2015","journal-title":"PLoS One"},{"key":"2020091210441376900_CIT0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2015.08.010","article-title":"Cytomegalovirus quantification in plasma with Abbott RealTime CMV and Roche Cobas Amplicor CMV assays","volume":"225","author":"Tremblay","year":"2015","journal-title":"J Virol Methods"},{"key":"2020091210441376900_CIT0037","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/infdis\/jit434","article-title":"Virologic correlates of anti-CMV IgG levels in HIV-1-infected men","volume":"209","author":"Gianella","year":"2014","journal-title":"J Infect Dis"},{"key":"2020091210441376900_CIT0038","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The Third International Consensus Guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciz1001\/31171326\/ciz1001.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/71\/6\/1438\/33738606\/ciz1001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/71\/6\/1438\/33738606\/ciz1001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T14:45:01Z","timestamp":1599921901000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/71\/6\/1438\/5586739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,14]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,10,14]]},"published-print":{"date-parts":[[2020,9,12]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciz1001","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9,15]]},"published":{"date-parts":[[2019,10,14]]}}}